All Stories

  1. Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), September 2021, De Gruyter

    Dr Maria Rosaria Capobianchi

  2. Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agents

    Article • Infection and Drug Resistance, November 2018, Dove Medical Press

    Dr Maria Rosaria Capobianchi, Anna Rosa Garbuglia

  3. Global epidemiology of viral hepatitis and national needs for complete control

    Article • Expert Review of Anti-infective Therapy, August 2018, Taylor & Francis

    Dr Maria Rosaria Capobianchi

  4. ZIKV Infection Induces an Inflammatory Response but Fails to Activate Types I, II, and III IFN Response in Human PBMC

    Article • Mediators of Inflammation, June 2018, Hindawi Publishing Corporation

    Dr Maria Rosaria Capobianchi, Giuseppe Ippolito

  5. Diagnosis of Zika virus infection in pregnant women travelling to or residing in endemic areas

    Article • The Lancet Infectious Diseases, July 2016, Elsevier

    Dr Maria Rosaria Capobianchi

  6. In-Depth Analysis of HA and NS1 Genes in A(H1N1)pdm09 Infected Patients

    Article • PLoS ONE, May 2016, PLOS

    Dr Maria Rosaria Capobianchi

  7. Temporal trend of hospital discharge for non alcoholic cirrhosis in Lazio Region, Italy 2000–2014

    Article • European Journal of Internal Medicine, May 2016, Elsevier

    Dr Maria Rosaria Capobianchi

  8. Clinical, Virologic, and Epidemiologic Characteristics of Dengue Outbreak, Dar es Salaam, Tanzania, 2014

    Article • Emerging Infectious Diseases, May 2016, Centers for Disease Control and Prevention (CDC)

    Dr Maria Rosaria Capobianchi, Ndekya Oriyo

  9. Genetic diversity of the haemagglutinin (HA) of human influenza a (H1N1) virus in montenegro: Focus on its origin and evolution

    Article • Journal of Medical Virology, April 2016, Wiley

    Dr Maria Rosaria Capobianchi, massimo ciccozzi

  10. Non-randomised Ebola trials—lessons for optimal outbreak research

    Article • The Lancet Infectious Diseases, April 2016, Elsevier

    Dr Maria Rosaria Capobianchi

  11. Extracellular Matrix Molecular Remodeling in Human Liver Fibrosis Evolution

    Article • PLoS ONE, March 2016, PLOS

    Dr Maria Rosaria Capobianchi

  12. Sampling Surfaces for Ebola Virus Persistence After Cleaning Procedures in High-Level Isolation Settings: The Experience With 2 Patients at the Lazzaro Spallanzani National Institute for Infectious Diseases

    Article • Infection Control, March 2016, Cambridge University Press

    Dr Maria Rosaria Capobianchi

  13. Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort

    Article • Clinical Microbiology and Infection, March 2016, Elsevier

    Dr Maria Rosaria Capobianchi

  14. Discontinuation of Initial Antiretroviral Therapy in Clinical Practice

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, March 2016, Wolters Kluwer Health

    Dr Maria Rosaria Capobianchi

  15. Key Role of Sequencing to Trace Hepatitis A Viruses Circulating in Italy During a Large Multi-Country European Foodborne Outbreak in 2013

    Article • PLoS ONE, February 2016, PLOS

    Dr Maria Rosaria Capobianchi

  16. Evaluation of the Aptima®HIV-1 Quant Dx assay for HIV-1 RNA viral load detection and quantitation in plasma of HIV-1-infected individuals: A comparison with Abbott RealTime HIV-1 assay

    Article • Journal of Medical Virology, February 2016, Wiley

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  17. A Follow-Up of the Multicenter Collaborative Study on HIV-1 Drug Resistance and Tropism Testing Using 454 Ultra Deep Pyrosequencing

    Article • PLoS ONE, January 2016, PLOS

    Dr Maria Rosaria Capobianchi

  18. Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus

    Article • PLoS ONE, December 2015, PLOS

    Dr Maria Rosaria Capobianchi

  19. Criteria for discharge of patients with Ebola virus diseases in high-income countries

    Article • The Lancet Global Health, December 2015, Elsevier

    Dr Maria Rosaria Capobianchi

  20. Blood kinetics of Ebola virus in survivors and nonsurvivors

    Article • Journal of Clinical Investigation, November 2015, American Society for Clinical Investigation

    Dr Maria Rosaria Capobianchi

  21. Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis

    Article • Proceedings of the National Academy of Sciences, November 2015, Proceedings of the National Academy of Sciences

    Dr Maria Rosaria Capobianchi

  22. HCV NS3 quasispecies in liver and plasma and dynamics of telaprevir-resistant variants in breakthrough patients assessed by UDPS: A case study

    Article • Journal of Clinical Virology, November 2015, Elsevier

    Dr Maria Rosaria Capobianchi

  23. Ebola: missed opportunities for Europe–Africa research

    Article • The Lancet Infectious Diseases, November 2015, Elsevier

    Dr Maria Rosaria Capobianchi

  24. An anal cancer screening program for MSM in Italy: Prevalence of multiple HPV types and vaccine-targeted infections

    Article • Journal of Clinical Virology, November 2015, Elsevier

    Dr Maria Rosaria Capobianchi

  25. Epidemiology of Hepatitis E Virus in European Countries

    Article • International Journal of Molecular Sciences, October 2015, MDPI AG

    Dr Maria Rosaria Capobianchi

  26. Ebola virus disease complicated with viral interstitial pneumonia: a case report

    Article • BMC Infectious Diseases, October 2015, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  27. Molecular Signature of the Ebola Virus Associated with the Fishermen Community Outbreak in Aberdeen, Sierra Leone, in February 2015

    Article • Genome Announcements, September 2015, ASM Journals

    Dr Maria Rosaria Capobianchi

  28. Liver transplant recipients and prioritization of anti-HCV therapy: an Italian cohort analysis

    Article • Liver International, September 2015, Wiley

    Dr Maria Rosaria Capobianchi

  29. The clinical significance of HCV core antigen detection during Telaprevir/Peg-Interferon/Ribavirin therapy in patients with HCV 1 genotype infection

    Article • Journal of Clinical Virology, August 2015, Elsevier

    Dr Maria Rosaria Capobianchi

  30. Erratum to ‘Dynamics of HCV genotype 4 resistance-associated variants during virologic escape with pIFN/RBV+daclatasvir: A case study using ultra deep pyrosequencing’ [Journal of Clinical Virology 66 (2015) 38–43]

    Article • Journal of Clinical Virology, August 2015, Elsevier

    Dr Maria Rosaria Capobianchi

  31. Hospital preparedness for knowledge-based response to Ebola and other emerging infectious diseases: A continuous challenge

    Article • European Journal of Internal Medicine, July 2015, Elsevier

    Dr Maria Rosaria Capobianchi

  32. Near full length hepatitis C virus genome reconstruction by next generation sequencing based on genotype-independent amplification

    Article • Digestive and Liver Disease, July 2015, Elsevier

    Dr Maria Rosaria Capobianchi

  33. Epidemiology of HEV in the Mediterranean basin: 10-year prevalence in Italy

    Article • BMJ Open, July 2015, BMJ

    Dr Maria Rosaria Capobianchi

  34. The added value of long-lasting preparedness for the management of a patient with Ebola

    Article • European Journal of Internal Medicine, July 2015, Elsevier

    Dr Maria Rosaria Capobianchi

  35. Molecular Characterization of the First Ebola Virus Isolated in Italy, from a Health Care Worker Repatriated from Sierra Leone

    Article • Genome Announcements, June 2015, ASM Journals

    Dr Maria Rosaria Capobianchi

  36. Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa

    Article • Nature, June 2015, Nature

    Dr Maria Rosaria Capobianchi

  37. The chronology of the international response to Ebola in Western Africa: lights and shadows in a frame of conflicting position and figures

    Article • Infectious Disease Reports, May 2015, PAGEPress Publications

    Dr Maria Rosaria Capobianchi

  38. Molecular mechanisms of Ebola virus pathogenesis: focus on cell death

    Article • Cell Death and Differentiation, May 2015, Nature

    Dr Maria Rosaria Capobianchi

  39. Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: data from the Icona Foundation cohort

    Article • HIV Medicine, May 2015, Wiley

    Dr Maria Rosaria Capobianchi

  40. Evaluation of the Prognostic Value of Impaired Renal Function on Clinical Progression in a Large Cohort of HIV-Infected People Seen for Care in Italy

    Article • PLoS ONE, May 2015, PLOS

    Dr Maria Rosaria Capobianchi

  41. Dynamics of HCV genotype 4 resistance-associated variants during virologic escape with pIFN/RBV+daclatasvir: A case study using ultra deep pyrosequencing

    Article • Journal of Clinical Virology, May 2015, Elsevier

    Dr Maria Rosaria Capobianchi

  42. Type I IFN family members: Similarity, differences and interaction

    Article • Cytokine & Growth Factor Reviews, April 2015, Elsevier

    Dr Maria Rosaria Capobianchi

  43. West Nile Virus Outbreak in the Lombardy Region, Northern Italy, Summer 2013

    Article • Vector-Borne and Zoonotic Diseases, April 2015, Mary Ann Liebert Inc

    Dr Maria Rosaria Capobianchi, Mattia Calzolari

  44. CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study

    Article • The Lancet HIV, March 2015, Elsevier

    Dr Maria Rosaria Capobianchi

  45. Bone marrow CD34+ progenitor cells may harbour HIV-DNA even in successfully treated patients

    Article • Clinical Microbiology and Infection, March 2015, Elsevier

    Dr Maria Rosaria Capobianchi

  46. Antagonistic Antiviral Activity between IFN-Lambda and IFN-Alpha against Lethal Crimean-Congo Hemorrhagic Fever Virus In Vitro

    Article • PLoS ONE, February 2015, PLOS

    Dr Maria Rosaria Capobianchi

  47. IFNL4 and IFNL3 Associated Polymorphisms Strongly Influence the Spontaneous IFN-Alpha Receptor-1 Expression in HCV-Infected Patients

    Article • PLoS ONE, February 2015, PLOS

    Dr Maria Rosaria Capobianchi

  48. Is hepatitis C virus eradication around the corner only 25 years after its discovery?

    Article • International Journal of Antimicrobial Agents, February 2015, Elsevier

    Dr Maria Rosaria Capobianchi

  49. Chikungunya and Its Interaction With the Host Cell

    Article • Current Tropical Medicine Reports, January 2015, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  50. Male patient with acute hepatitis E in Genoa, Italy: figatelli (pork liver sausage) as probable source of the infection

    Article • Clinical Microbiology and Infection, January 2015, Elsevier

    Dr Maria Rosaria Capobianchi

  51. First Reported Chikungunya Fever Outbreak in the Republic of Congo, 2011

    Article • PLoS ONE, December 2014, PLOS

    Dr Maria Rosaria Capobianchi

  52. Hepatitis C virus treatment revolution: need for close monitoring

    Article • Clinical Microbiology and Infection, November 2014, Elsevier

    Dr Maria Rosaria Capobianchi

  53. Acute HIV infection (AHI) in a specialized clinical setting: case-finding, description of virological, epidemiological and clinical characteristics

    Article • Journal of the International AIDS Society, November 2014, Wiley

    Dr Maria Rosaria Capobianchi

  54. Randomized trial of DRV/r or LPV/r QD monotherapy vs maintaining a PI/r-based antiretroviral regimen in persons with suppressed HIV replication

    Article • Journal of the International AIDS Society, November 2014, Wiley

    Dr Maria Rosaria Capobianchi

  55. Performances of Bioinformatics Pipelines for the Identification of Pathogens in Clinical Samples with the De Novo Assembly Approaches: Focus on 2009 Pandemic Influenza A (H1N1)

    Article • The Open Bioinformatics Journal, October 2014, Bentham Science Publishers

    Dr Maria Rosaria Capobianchi

  56. Evaluation in a clinical setting of the performances of a new rapid confirmatory assay for HIV1/2 serodiagnosis

    Article • Journal of Clinical Virology, September 2014, Elsevier

    Dr Maria Rosaria Capobianchi

  57. Cellular and Humoral Cross-Immunity against Two H3N2v Influenza Strains in Presumably Unexposed Healthy and HIV-Infected Subjects

    Article • PLoS ONE, August 2014, PLOS

    Dr Maria Rosaria Capobianchi

  58. Acute fulminant hepatitis E virus genotype 3e infection: Description of the first case in Europe

    Article • Scandinavian Journal of Infectious Diseases, August 2014, Taylor & Francis

    Dr Maria Rosaria Capobianchi

  59. An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencing

    Article • Journal of Virological Methods, August 2014, Elsevier

    Dr Maria Rosaria Capobianchi

  60. Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure

    Article • Journal of Antimicrobial Chemotherapy, July 2014, Oxford University Press (OUP)

    Dr Maria Rosaria Capobianchi

  61. Detection of HIV-1 Matrix Protein p17 Quasispecies Variants in Plasma of Chronic HIV-1–Infected Patients by Ultra-Deep Pyrosequencing

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, July 2014, Wolters Kluwer Health

    Dr Maria Rosaria Capobianchi

  62. A Large Epidemic of Hepatitis B in Serbia: An Integrated Model for Outbreak Investigations in Healthcare Settings

    Article • Infection Control and Hospital Epidemiology, June 2014, Cambridge University Press

    Dr Maria Rosaria Capobianchi

  63. HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

    Article • BMC Infectious Diseases, April 2014, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  64. IFN-Alpha Receptor-1 Upregulation in PBMC from HCV Naïve Patients Carrying CC Genotype. Possible Role of IFN-Lambda

    Article • PLoS ONE, April 2014, PLOS

    Dr Maria Rosaria Capobianchi

  65. No impact of interleukin-28B polymorphisms on spontaneous or drug-induced hepatitis delta virus clearance

    Article • Digestive and Liver Disease, April 2014, Elsevier

    Dr Maria Rosaria Capobianchi

  66. Molecular characterization of hepatitis A outbreak in the province of Rome, Lazio region, Italy, January–July 2013

    Article • Microbes and Infection, April 2014, Elsevier

    Dr Maria Rosaria Capobianchi

  67. Ability of Two Commercially Available Assays (Abbott RealTime HIV-1 and Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Version 2.0) To Quantify Low HIV-1 RNA Levels (<1,000 Copies/Milliliter): Comparison with Clinical Samples and NIBSC Working Reagent for Nu...

    Article • Journal of Clinical Microbiology, March 2014, ASM Journals

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  68. Quasispecies tropism and compartmentalization in gut and peripheral blood during early and chronic phases of HIV-1 infection: possible correlation with immune activation markers

    Article • Clinical Microbiology and Infection, March 2014, Elsevier

    Dr Maria Rosaria Capobianchi

  69. Brain localization of Kaposi’s sarcoma in a patient treated by combination antiretroviral therapy

    Article • BMC Infectious Diseases, December 2013, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  70. Large Human Outbreak of West Nile Virus Infection in North-Eastern Italy in 2012

    Article • Viruses, November 2013, MDPI AG

    Professor Luisa Barzon, Dr Maria Rosaria Capobianchi

  71. Extent of HCV NS3 protease variability and resistance-associated mutations assessed by next generation sequencing in HCV monoinfected and HIV/HCV coinfected patients

    Article • Virus Research, November 2013, Elsevier

    Dr Maria Rosaria Capobianchi

  72. Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy

    Article • Journal of Antimicrobial Chemotherapy, October 2013, Oxford University Press (OUP)

    Dr Maria Rosaria Capobianchi

  73. Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group

    Article • Infection, October 2013, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  74. The potential impact of routine testing of individuals with HIV indicator diseases in order to prevent late HIV diagnosis

    Article • BMC Infectious Diseases, October 2013, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  75. Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: a cohort study

    Article • BMC Infectious Diseases, October 2013, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi, Dr. Vicente Soriano

  76. Diagnosis of West Nile Virus Human Infections: Overview and Proposal of Diagnostic Protocols Considering the Results of External Quality Assessment Studies

    Article • Viruses, September 2013, MDPI AG

    Dr Maria Rosaria Capobianchi, PhD Andrea Sanchini

  77. HIV-1 drug resistance in recently HIV-infected pregnant mother’s naïve to antiretroviral therapy in Dodoma urban, Tanzania

    Article • BMC Infectious Diseases, September 2013, Springer Science + Business Media

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  78. The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case–control study

    Article • BMC Infectious Diseases, September 2013, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  79. West Nile virus in Europe: emergence, epidemiology, diagnosis, treatment, and prevention

    Article • Clinical Microbiology and Infection, August 2013, Elsevier

    Dr Maria Rosaria Capobianchi

  80. Detection of haemagglutinin D222 polymorphisms in influenza A(H1N1)pdm09-infected patients by ultra-deep pyrosequencing

    Article • Clinical Microbiology and Infection, July 2013, Elsevier

    Dr Maria Rosaria Capobianchi

  81. Structural dynamics of V3 loop with different electrostatics: implications on co-receptor recognition: a molecular dynamics study of HIV gp120

    Article • Journal of Biomolecular Structure and Dynamics, April 2013, Taylor & Francis

    Dr Maria Rosaria Capobianchi

  82. In Vivo Interferon-Alpha/Ribavirin Treatment Modulates Vγ9Vδ2 T-Cell Function During Chronic HCV Infection

    Article • Journal of Interferon & Cytokine Research, March 2013, Mary Ann Liebert Inc

    Dr Maria Rosaria Capobianchi

  83. Comparison of the Abbott RealTime High Risk HPV with Genomica HPV Clinical Array for the detection of human papillomavirus DNA

    Article • Apmis, February 2013, Wiley

    Dr Maria Rosaria Capobianchi

  84. Biosafety Level-4 Laboratories in Europe: Opportunities for Public Health, Diagnostics, and Research

    Article • PLoS Pathogens, January 2013, PLOS

    Dr Maria Rosaria Capobianchi

  85. The Genotypic False Positive Rate Determined by V3 Population Sequencing Can Predict the Burden of HIV-1 CXCR4-using Species Detected by Pyrosequencing

    Article • PLoS ONE, January 2013, PLOS

    Dr Maria Rosaria Capobianchi

  86. In vivo IFN-alpha/ribavirin treatment modulates Vgamma9delta2 T-cell function during chronic HCV infection

    Article • Frontiers in Immunology, January 2013, Frontiers

    Dr Maria Rosaria Capobianchi

  87. Slow response to entecavir treatment in treatment-naive HBV patients is conditioned by immune response rather than by the presence or selection of refractory variants

    Article • Antiviral Therapy, January 2013, International Medical Press

    Dr Maria Rosaria Capobianchi

  88. Next-generation sequencing technology in clinical virology

    Article • Clinical Microbiology and Infection, January 2013, Elsevier

    Dr Maria Rosaria Capobianchi

  89. Hepatitis E Virus Genotype 4 Outbreak, Italy, 2011

    Article • Emerging Infectious Diseases, January 2013, Centers for Disease Control and Prevention (CDC)

    Dr Maria Rosaria Capobianchi

  90. Cellular and Humoral Immune Responses to Pandemic Influenza Vaccine in Healthy and in Highly Active Antiretroviral Therapy-Treated HIV Patients

    Article • AIDS Research and Human Retroviruses, December 2012, Mary Ann Liebert Inc

    Dr Maria Rosaria Capobianchi

  91. Heterogeneity of West Nile virus genotype 1a in Italy, 2011

    Article • Journal of General Virology, November 2012, Society for General Microbiology

    Dr Maria Rosaria Capobianchi

  92. Exposure to Abacavir and Biomarkers of Cardiovascular Disease in HIV-1–Infected Patients on Suppressive Antiretroviral Therapy

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, July 2012, Wolters Kluwer Health

    Dr Maria Rosaria Capobianchi

  93. Frequency and multiplicity of human papillomavirus infection in HIV-1 positive women in Italy

    Article • Journal of Clinical Virology, June 2012, Elsevier

    Dr Maria Rosaria Capobianchi

  94. Interferon-α Improves Phosphoantigen-Induced Vγ9Vδ2 T-Cells Interferon-γ Production during Chronic HCV Infection

    Article • PLoS ONE, May 2012, PLOS

    Dr Maria Rosaria Capobianchi

  95. Monophyletic outbreak of Hepatitis A involving HIV-infected men who have sex with men, Rome, Italy 2008–2009

    Article • Journal of Clinical Virology, May 2012, Elsevier

    Dr Maria Rosaria Capobianchi

  96. Erratum to “Standardization and performance evaluation of “modified” and “ultrasensitive” versions of the Abbott RealTime HIV-1 assay, adapted to quantify minimal residual viremia” [J. Clin. Virol. 52 (2011) 17–22]

    Article • Journal of Clinical Virology, February 2012, Elsevier

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  97. Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts

    Article • Journal of Antimicrobial Chemotherapy, January 2012, Oxford University Press (OUP)

    Dr Maria Rosaria Capobianchi

  98. HCV full-length genome reconstruction with sequence independent amplification combined with next generation sequencing

    Article • Retrovirology, January 2012, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  99. HDV-RNA and HBsAg Evolution during peg-IFN Treatment in Three HBV-HDV-HCV-HIV Coinfected Patients

    Article • World Journal of AIDS, January 2012, Scientific Research Publishing, Inc,

    Dr Maria Rosaria Capobianchi

  100. Seroprevalence of dengue infection: a cross-sectional survey in mainland Tanzania and on Pemba Island, Zanzibar

    Article • International Journal of Infectious Diseases, January 2012, Elsevier

    Dr Maria Rosaria Capobianchi

  101. Viral hemorrhagic fevers: advancing the level of treatment

    Article • BMC Medicine, January 2012, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  102. Comparison of two real-time RT-PCR-based systems for the detection and typing of the pandemic influenza A virus, 2009

    Article • Journal of Virological Methods, November 2011, Elsevier

    Dr Maria Rosaria Capobianchi

  103. Metagenomic approach for discovering new pathogens in infection disease outbreaks

    Article • Microbiologia Medica, September 2011, PAGEPress Publications

    Dr Maria Rosaria Capobianchi

  104. 'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing

    Article • Journal of Antimicrobial Chemotherapy, September 2011, Oxford University Press (OUP)

    Dr Maria Rosaria Capobianchi

  105. Standardization and performance evaluation of “modified” and “ultrasensitive” versions of the Abbott RealTime HIV-1 assay, adapted to quantify minimal residual viremia

    Article • Journal of Clinical Virology, September 2011, Elsevier

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  106. Deep Sequencing of Plasma and Proviral HIV-1 to Establish Coreceptor Usage: What Is the Clinical Impact of the Quasispecies Distribution?

    Article • The Journal of Infectious Diseases, August 2011, Oxford University Press (OUP)

    Dr Maria Rosaria Capobianchi

  107. Cowpox Virus in Llama, Italy

    Article • Emerging Infectious Diseases, August 2011, Centers for Disease Control and Prevention (CDC)

    Dr Maria Rosaria Capobianchi

  108. MYO1E Mutations and Childhood Familial Focal Segmental Glomerulosclerosis

    Article • New England Journal of Medicine, July 2011, New England Journal of Medicine (NEJM/MMS)

    Dr Maria Rosaria Capobianchi

  109. High HIV prevalence in male patients with acute hepatitis A in the Rome metropolitan area, Italy 2002–2008

    Article • Journal of Hepatology, June 2011, Elsevier

    Dr Maria Rosaria Capobianchi

  110. Improving clinical laboratory efficiency: a time-motion evaluation of the Abbott m2000 RealTime and Roche COBAS AmpliPrep/COBAS TaqMan PCR systems for the simultaneous quantitation of HIV-1 RNA and HCV RNA

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), May 2011, De Gruyter

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  111. Duration of viral shedding in hospitalized patients infected with pandemic H1N1

    Article • BMC Infectious Diseases, May 2011, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  112. Phylogenetic Analysis of West Nile Virus Isolates, Italy, 2008–2009

    Article • Emerging Infectious Diseases, May 2011, Centers for Disease Control and Prevention (CDC)

    Dr Maria Rosaria Capobianchi

  113. Analysis of co‐receptor usage of circulating viral and proviral HIV genome quasispecies by ultra‐deep pyrosequencing in patients who are candidates for CCR5 antagonist treatment

    Article • Clinical Microbiology and Infection, May 2011, Elsevier

    Dr Maria Rosaria Capobianchi

  114. Hepatitis E virus in Italy: molecular analysis of travel-related and autochthonous cases

    Article • Journal of General Virology, April 2011, Society for General Microbiology

    Dr Maria Rosaria Capobianchi

  115. Hemagglutinin 222 Variants in Pandemic (H1N1) 2009 Virus

    Article • Emerging Infectious Diseases, April 2011, Centers for Disease Control and Prevention (CDC)

    Dr Maria Rosaria Capobianchi

  116. Multicenter comparative study of Epstein–Barr virus DNA quantification for virological monitoring in transplanted patients

    Article • Journal of Clinical Virology, March 2011, Elsevier

    Dr Maria Rosaria Capobianchi

  117. Detection of quasispecies variants predicted to use CXCR4 by ultra-deep pyrosequencing during early HIV infection

    Article • AIDS, March 2011, Wolters Kluwer Health

    Dr Maria Rosaria Capobianchi

  118. The basal activation state of DC subsets correlates with anti-HCV treatment outcome in HCV/HIV co-infected patients

    Article • Clinical Immunology, February 2011, Elsevier

    Dr Maria Rosaria Capobianchi

  119. Retrospective Investigation of an Influenza A/H1N1pdm Outbreak in an Italian Military Ship Cruising in the Mediterranean Sea, May-September 2009

    Article • PLoS ONE, January 2011, PLOS

    Dr Maria Rosaria Capobianchi

  120. Effect of raltegravir on the total and unintegrated proviral HIV DNA during raltegravir-based HAART

    Article • Antiviral Therapy, January 2011, International Medical Press

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  121. Combinatorial analysis and algorithms for quasispecies reconstruction using next-generation sequencing

    Article • BMC Bioinformatics, January 2011, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  122. Alkhurma Hemorrhagic Fever in Travelers Returning from Egypt, 2010

    Article • Emerging Infectious Diseases, December 2010, Centers for Disease Control and Prevention (CDC)

    Dr Maria Rosaria Capobianchi

  123. Association of Profoundly Impaired Immune Competence in H1N1v‐Infected Patients with a Severe or Fatal Clinical Course

    Article • The Journal of Infectious Diseases, September 2010, Oxford University Press (OUP)

    Dr Maria Rosaria Capobianchi

  124. Molecular epidemiology of a hepatitis C virus epidemic in a haemodialysis unit: outbreak investigation and infection outcome

    Article • BMC Infectious Diseases, August 2010, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  125. Absence of Neuroinvasive Disease in a Liver Transplant Recipient Who Acquired West Nile Virus (WNV) Infection from the Organ Donor and Who Received WNV Antibodies Prophylactically

    Article • Clinical Infectious Diseases, August 2010, Oxford University Press (OUP)

    Dr Maria Rosaria Capobianchi

  126. The prevalence of antibodies to human herpesvirus 8 and hepatitis B virus in patients in two hospitals in Tanzania

    Article • Journal of Medical Virology, July 2010, Wiley

    Dr Maria Rosaria Capobianchi

  127. Minimal residual HIV viremia: verification of the Abbott Real-Time HIV-1 assay sensitivity

    Article • Microbiologia Medica, June 2010, PAGEPress Publications

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  128. Frequency of Detection of Upper Respiratory Tract Viruses in Patients Tested for Pandemic H1N1/09 Viral Infection

    Article • Journal of Clinical Microbiology, June 2010, ASM Journals

    Dr Maria Rosaria Capobianchi

  129. Prevalence study of HPV mixed infections in Italian HIV positive women

    Article • Microbiologia Medica, June 2010, PAGEPress Publications

    Dr Maria Rosaria Capobianchi

  130. Pre-analytic phase in molecular biology: criticism and non-compliance management

    Article • Microbiologia Medica, June 2010, PAGEPress Publications

    Dr Maria Rosaria Capobianchi

  131. Evolutionary pattern of pandemic influenza (H1N1) 2009 virus in the late phases of the 2009 pandemic.

    Article • PLoS Currents, March 2010, PLOS

    Dr Maria Rosaria Capobianchi

  132. Comparison of real-time PCR methods for measurement of HIV-1 proviral DNA

    Article • Journal of Virological Methods, March 2010, Elsevier

    Dr Maria Rosaria Capobianchi

  133. Design and clinical application of a molecular method for detection and typing of the influenza A/H1N1pdm virus

    Article • Journal of Virological Methods, February 2010, Elsevier

    Dr Maria Rosaria Capobianchi

  134. Critical reappraisal of the A226V mutation in Chikungunya outbreaks: possible role in increased pathogenesis?

    Article • Microbiologia Medica, December 2009, PAGEPress Publications

    Dr Maria Rosaria Capobianchi

  135. Low‐Abundance Drug Resistance Mutations: Extending the HIV Paradigm to Hepatitis B Virus

    Article • The Journal of Infectious Diseases, December 2009, Oxford University Press (OUP)

    Dr Maria Rosaria Capobianchi

  136. European Perspective of 2-Person Rule for Biosafety Level 4 Laboratories

    Article • Emerging Infectious Diseases, November 2009, Centers for Disease Control and Prevention (CDC)

    Dr Maria Rosaria Capobianchi

  137. Archived HIV-1 minority variants detected by ultra-deep pyrosequencing in provirus may be fully replication competent

    Article • AIDS, November 2009, Wolters Kluwer Health

    Dr Maria Rosaria Capobianchi

  138. Recombinant interferon-α2b improves immune response to hepatitis B vaccination in haemodialysis patients: Results of a randomised clinical trial

    Article • Vaccine, September 2009, Elsevier

    Dr Maria Rosaria Capobianchi

  139. Use of Massive Parallel Pyrosequencing for Near Full-Length Characterization of a Unique HIV Type 1 BF Recombinant Associated with a Fatal Primary Infection

    Article • AIDS Research and Human Retroviruses, September 2009, Mary Ann Liebert Inc

    Dr Maria Rosaria Capobianchi

  140. Viral Interference Between Hepatitis B, C, and D Viruses in Dual and Triple Infections in HIV-Positive Patients

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, August 2009, Wolters Kluwer Health

    Dr Maria Rosaria Capobianchi

  141. The European network of Biosafety-Level-4 laboratories: enhancing European preparedness for new health threats

    Article • Clinical Microbiology and Infection, August 2009, Elsevier

    Dr Maria Rosaria Capobianchi

  142. Facing the threat of highly infectious diseases in Europe: the need for a networking approach

    Article • Clinical Microbiology and Infection, August 2009, Elsevier

    Dr Maria Rosaria Capobianchi

  143. Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs

    Article • BMC Infectious Diseases, July 2009, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  144. Transgenic chloroplasts are efficient sites for high‐yield production of the vaccinia virus envelope protein A27L in plant cells†

    Article • Plant Biotechnology Journal, July 2009, Wiley

    Dr manuela de carlo, Dr Maria Rosaria Capobianchi

  145. A sensitive direct sequencing assay based on nested PCR for the detection of HBV polymerase and surface glycoprotein mutations

    Article • Journal of Virological Methods, July 2009, Elsevier

    Dr Maria Rosaria Capobianchi

  146. Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B

    Article • Journal of Medical Virology, July 2009, Wiley

    Dr Maria Rosaria Capobianchi

  147. Lack of implementation of Hepatitis B Virus (HBV) vaccination policy in household contacts of HBV carriers in Italy

    Article • BMC Infectious Diseases, June 2009, Springer Science + Business Media

    tiziana russo spena , Dr Maria Rosaria Capobianchi

  148. Accuracy of a Commercial Real‐Time Polymerase Chain Reaction–Based System for Measurement of HIV RNA Levels around the Limit of Quantification of the Assay

    Article • Clinical Infectious Diseases, June 2009, Oxford University Press (OUP)

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  149. Crimean-Congo Hemorrhagic Fever, Southwestern Bulgaria

    Article • Emerging Infectious Diseases, June 2009, Centers for Disease Control and Prevention (CDC)

    Dr Maria Rosaria Capobianchi

  150. Impact of Preemptive Reduction of Immunosuppression With Serial Monitoring for BK Virus Replication in Renal Transplant Recipients Undergoing Short-Term Evaluation

    Article • Transplantation Proceedings, May 2009, Elsevier

    Dr Maria Rosaria Capobianchi

  151. Impact of viral selected mutations on T cell mediated immunity in chronically evolving and self limiting acute HCV infection

    Article • Virology, April 2009, Elsevier

    Dr Maria Rosaria Capobianchi

  152. Cat-to-Human Orthopoxvirus Transmission, Northeastern Italy

    Article • Emerging Infectious Diseases, March 2009, Centers for Disease Control and Prevention (CDC)

    Dr Maria Rosaria Capobianchi

  153. Massively parallel pyrosequencing highlights minority variants in the HIV-1 env quasispecies deriving from lymphomonocyte sub-populations

    Article • Retrovirology, January 2009, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  154. Use of Massively Parallel Ultradeep Pyrosequencing To Characterize the Genetic Diversity of Hepatitis B Virus in Drug-Resistant and Drug-Naive Patients and To Detect Minor Variants in Reverse Transcriptase and Hepatitis B S Antigen

    Article • Journal of Virology, December 2008, ASM Journals

    Dr Maria Rosaria Capobianchi

  155. 315 Activation of interferon response in human PBMC by Avian influenza H5N1 virus

    Article • Cytokine, September 2008, Elsevier

    Dr Maria Rosaria Capobianchi

  156. Phylogenetic analysis of human coronavirus NL63 circulating in Italy

    Article • Journal of Clinical Virology, September 2008, Elsevier

    Dr Maria Rosaria Capobianchi

  157. Presence of the A226V Mutation in Autochthonous and Imported Italian Chikungunya Virus Strains

    Article • Clinical Infectious Diseases, August 2008, Oxford University Press (OUP)

    Dr Maria Rosaria Capobianchi

  158. Influenza Pandemics, Immune Cross‐Reactivity, and Pandemic Control Strategies

    Article • The Journal of Infectious Diseases, July 2008, Oxford University Press (OUP)

    Dr Maria Rosaria Capobianchi

  159. Networking for infectious-disease emergencies in Europe

    Article • Nature Reviews Microbiology, July 2008, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  160. Evaluation of an automated extraction system in combination with Affigene® CMV Trender for CMV DNA quantitative determination: Comparison with nested PCR and pp65 antigen test

    Article • Journal of Virological Methods, July 2008, Elsevier

    Dr Maria Rosaria Capobianchi

  161. Ebolavirus and Marburgvirus: Insight the Filoviridae family

    Article • Molecular Aspects of Medicine, June 2008, Elsevier

    Dr Maria Rosaria Capobianchi, Professor Martino Bolognesi

  162. Plasma HIV RNA Decline and Emergence of Drug Resistance Mutations among Patients with Multiple Virologic Failures Receiving Resistance Testing-Guided HAART

    Article • AIDS Research and Human Retroviruses, June 2008, Mary Ann Liebert Inc

    Dr Maria Rosaria Capobianchi

  163. The use of molecular assays in the management of viral hepatitis

    Article • Digestive and Liver Disease, June 2008, Elsevier

    Dr Maria Rosaria Capobianchi

  164. Frequency of detection of respiratory viruses in the lower respiratory tract of hospitalized adults

    Article • Journal of Clinical Virology, June 2008, Elsevier

    Dr Maria Rosaria Capobianchi

  165. GB Virus Type C–Driven Protection in HIV/HCV Coinfection: Possible Role of Interferon Gamma and Dendritic Cell Activation

    Article • Gastroenterology, May 2008, Elsevier

    Dr Maria Rosaria Capobianchi

  166. GB-Virus Type C Effect on HIV Infection, Interferon System, and Dendritric Cells

    Article • Archives of Medical Research, April 2008, Elsevier

    Dr Maria Rosaria Capobianchi

  167. Evaluation of the effects of human leukocyte IFN-α on the immune response to the HBV vaccine in healthy unvaccinated individuals

    Article • Vaccine, February 2008, Elsevier

    Dr Maria Rosaria Capobianchi

  168. Influence of specific CD4+ T cells and antibodies on evolution of hypervariable region 1 during acute HCV infection

    Article • Journal of Hepatology, February 2008, Elsevier

    Dr Maria Rosaria Capobianchi

  169. Comment on Neumann et al. ‘Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients’

    Article • AIDS, January 2008, Wolters Kluwer Health

    Dr Maria Rosaria Capobianchi

  170. Role of hepatitis B virus, hepatitis D virus and other determinants on suppression of hepatitis C viraemia in HIV infected patients with chronic HCV infection: A longitudinal evaluation

    Article • Scandinavian Journal of Infectious Diseases, January 2008, Taylor & Francis

    Dr Maria Rosaria Capobianchi

  171. Interferon May Prevent HIV Viral Rebound After HAART Interruption in HIV Patients

    Article • Journal of Interferon & Cytokine Research, January 2008, Mary Ann Liebert Inc

    Dr Maria Rosaria Capobianchi

  172. Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, December 2007, Wolters Kluwer Health

    Dr Maria Rosaria Capobianchi, Dr. Vicente Soriano

  173. Comparison of Versant HBV DNA 3.0 and COBAS AmpliPrep–COBAS TaqMan assays for hepatitis B DNA quantitation: Possible clinical implications

    Article • Journal of Virological Methods, December 2007, Elsevier

    Dr Maria Rosaria Capobianchi

  174. Effective Highly Active Antiretroviral Therapy in Patients With Primary HIV-1 Infection Prevents the Evolution of the Avidity of HIV-1-Specific Antibodies

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, October 2007, Wolters Kluwer Health

    Dr Maria Rosaria Capobianchi

  175. Reply to Bull et al.

    Article • The Journal of Infectious Diseases, August 2007, Oxford University Press (OUP)

    Dr Maria Rosaria Capobianchi

  176. The Effect of Age on Response to Therapy With Peginterferon ? Plus Ribavirin in a Cohort of Patients With Chronic HCV Hepatitis Including Subjects Older Than 65 Yr

    Article • The American Journal of Gastroenterology, July 2007, Nature

    Dr Maria Rosaria Capobianchi

  177. Fatal myocardial co-infection by Toxoplasma gondii and Parvovirus B19 in an HIV patient

    Article • AIDS, June 2007, Wolters Kluwer Health

    Dr Maria Rosaria Capobianchi

  178. Improved detection of human influenza A and B viruses in respiratory tract specimens by hemi-nested PCR

    Article • Journal of Virological Methods, May 2007, Elsevier

    Dr Maria Rosaria Capobianchi

  179. Simultaneous control of DNA and RNA processing efficiency using a nucleic acid calibration set

    Article • BioTechniques, April 2007, Future Science

    Dr Maria Rosaria Capobianchi

  180. Differential Expression of Werner and Bloom Syndrome Genes in the Peripheral Blood of HIV-1 Infected Patients

    Article • Human Immunology, February 2007, Elsevier

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  181. Molecular epidemiology of a hepatitis C virus outbreak in a hemodialysis unit in Italy

    Article • Journal of Medical Virology, January 2007, Wiley

    Dr Maria Rosaria Capobianchi

  182. Primary effusion lymphoma in pleural and pericardial cavities with multiple solid nodal and extra-nodal involvement in a human immunodeficiency virus-positive patient

    Article • Leukemia & Lymphoma, January 2007, Taylor & Francis

    Dr Maria Rosaria Capobianchi

  183. Virological characterization of patients treated early is able to control HIV-1 replication after multiple cycles of structured therapy interruption

    Article • Journal of Medical Virology, January 2007, Wiley

    Dr Maria Rosaria Capobianchi

  184. Markers of human papillomavirus infection and their correlation with cervical dysplasia in human immunodeficiency virus-positive women

    Article • Clinical Microbiology and Infection, January 2007, Elsevier

    Dr Maria Rosaria Capobianchi, Alessandra Pierangeli

  185. Possible Compartmentalization of Hepatitis C Viral Replication in the Genital Tract of HIV‐1–Coinfected Women

    Article • The Journal of Infectious Diseases, December 2006, Oxford University Press (OUP)

    Dr Maria Rosaria Capobianchi

  186. Il virus influenzale: una nuova pandemia dietro l’angolo?

    Article • Microbiologia Medica, June 2006, PAGEPress Publications

    Dr Maria Rosaria Capobianchi

  187. Interferon‐γ–Mediated Antiviral Immunity against Orthopoxvirus Infection Is Provided by γδ T Cells

    Article • The Journal of Infectious Diseases, June 2006, Oxford University Press (OUP)

    Dr Maria Rosaria Capobianchi

  188. Anti–Severe Acute Respiratory Syndrome Coronavirus Immune Responses: The Role Played by Vγ9Vδ2 T Cells

    Article • The Journal of Infectious Diseases, May 2006, Oxford University Press (OUP)

    Dr Maria Rosaria Capobianchi, Professor Paul KS Chan

  189. Patogenesi ed epidemiologia dei tumori associati all’infezione da virus di Epstein-Barr

    Article • Microbiologia Medica, March 2006, PAGEPress Publications

    Dr Maria Rosaria Capobianchi

  190. Trends in HIV Prevalence Among Pregnant Women in Italy, 1994 to 2002

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, March 2006, Wolters Kluwer Health

    Dr Maria Rosaria Capobianchi

  191. Activation of V 9V 2 T cells by non-peptidic antigens induces the inhibition of subgenomic HCV replication

    Article • International Immunology, November 2005, Oxford University Press (OUP)

    Dr Maria Rosaria Capobianchi

  192. BeadCons: Detection of Nucleic Acid Sequences by Flow Cytometry

    Article • November 2005, Wiley

    Dr Maria Rosaria Capobianchi

  193. Coordinate induction of IFN-α and -γ by SARS-CoV also in the absence of virus replication

    Article • Virology, October 2005, Elsevier

    Dr Maria Rosaria Capobianchi

  194. Rapid, differential diagnosis of orthopox- and herpesviruses based upon real-time PCR product melting temperature and restriction enzyme analysis of amplicons

    Article • Journal of Virological Methods, October 2005, Elsevier

    Dr Maria Rosaria Capobianchi

  195. Bcl-2 inhibits the caspase-dependent apoptosis induced by SARS-CoV without affecting virus replication kinetics

    Article • Archives of Virology, September 2005, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  196. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection

    Article • European Journal of Immunology, September 2005, Wiley

    Dr Maria Rosaria Capobianchi

  197. A Cluster of Hepatitis C Virus Infections Associated With Ozone-Enriched Transfusion of Autologous Blood in Rome, Italy

    Article • Infection Control, September 2005, Cambridge University Press

    Dr Maria Rosaria Capobianchi

  198. Effect of Hepatitis C Virus Genotype on CD4 + T Cell Count in a Cohort of Antiretroviral‐Naive HIV‐1–Infected Individuals

    Article • The Journal of Infectious Diseases, August 2005, Oxford University Press (OUP)

    Dr Maria Rosaria Capobianchi

  199. Application of a Molecular Panel To Demonstrate Enterotropic Virus Shedding by Healthy and Human Immunodeficiency Virus-Infected Patients

    Article • Journal of Clinical Microbiology, April 2005, ASM Journals

    Dr Maria Rosaria Capobianchi

  200. Rhinovirus and Lower Respiratory Tract Infection in Adults

    Article • Clinical Infectious Diseases, April 2005, Oxford University Press (OUP)

    Dr Maria Rosaria Capobianchi

  201. Cell membrane proteins and quasispecies compartmentalization of CSF and plasma HIV-1 from aids patients with neurological disorders

    Article • Infection Genetics and Evolution, April 2005, Elsevier

    Dr Maria Rosaria Capobianchi

  202. Antiviral reactivities of γδ T cells

    Article • Microbes and Infection, March 2005, Elsevier

    Dr Maria Rosaria Capobianchi

  203. Sepharose-bound, highly sulfated glycosaminoglycans can capture HIV-1 from culture medium

    Article • Carbohydrate Research, March 2005, Elsevier

    Dr Maria Rosaria Capobianchi

  204. Influence of GB Virus Type C and HIV Coinfection on    T cells

    Article • Clinical Infectious Diseases, January 2005, Oxford University Press (OUP)

    Dr Maria Rosaria Capobianchi

  205. Knowledge and use of papanicolaou test among HIV-positive women

    Article • International Journal of Cancer, January 2005, Wiley

    Dr Maria Rosaria Capobianchi

  206. Expression of Werner and Bloom syndrome genes is differentially regulated by in vitro HIV-1 infection of peripheral blood mononuclear cells

    Article • Clinical & Experimental Immunology, November 2004, Wiley

    Dr Maria Rosaria Capobianchi

  207. Intra-hepatic messenger RNA levels for interferons and related genes in hepatitis C virus/HIV co-infected patients

    Article • AIDS, August 2004, Wolters Kluwer Health

    Dr Maria Rosaria Capobianchi

  208. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes

    Article • The Lancet, July 2004, Elsevier

    Dr Maria Rosaria Capobianchi, Dr. Vicente Soriano

  209. Hemophagocytic Syndrome in a Patient with Acute Human Immunodeficiency Virus Infection

    Article • Clinical Infectious Diseases, June 2004, Oxford University Press (OUP)

    Dr Maria Rosaria Capobianchi

  210. HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin

    Article • Journal of Hepatology, May 2004, Elsevier

    Dr Maria Rosaria Capobianchi

  211. La diagnosi di infezione da HIV

    Article • Microbiologia Medica, March 2004, PAGEPress Publications

    Dr Maria Rosaria Capobianchi

  212. Intra-hepatic messenger RNA levels for interferons and related genes in hepatitis C virus/HIV co-infected patients

    Article • AIDS, March 2004, Wolters Kluwer Health

    Dr Maria Rosaria Capobianchi

  213. Inhibition of HIV‐1 Replication in Monocyte‐Derived Macrophages by Mycobacterium tuberculosis

    Article • The Journal of Infectious Diseases, February 2004, Oxford University Press (OUP)

    Dr Maria Rosaria Capobianchi

  214. Comparison of LCx with Other Current Viral Load Assays for Detecting and Quantifying Human Immunodeficiency Virus Type 1 RNA in Patients Infected with the Circulating Recombinant Form A/G (CRF02)

    Article • Journal of Clinical Microbiology, February 2004, ASM Journals

    Dr Maria Rosaria Capobianchi

  215. HIV-1 DNA burden dynamics in CD4 T cells and monocytes in patients undergoing a transient therapy interruption

    Article • Journal of Medical Virology, January 2004, Wiley

    Dr Maria Rosaria Capobianchi

  216. HIV Type 1 Replication in Cerebrospinal Fluid of Patients with AIDS-Related Non-Hodgkin's Lymphoma Receiving Chemotherapy and Antiretroviral Therapy

    Article • AIDS Research and Human Retroviruses, December 2003, Mary Ann Liebert Inc

    Dr Maria Rosaria Capobianchi

  217. Flow Cytometry and T-Cell Response Monitoring after Smallpox Vaccination

    Article • Emerging Infectious Diseases, November 2003, Centers for Disease Control and Prevention (CDC)

    Dr Maria Rosaria Capobianchi

  218. Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients

    Article • Journal of Medical Virology, June 2003, Wiley

    Dr Maria Rosaria Capobianchi

  219. Human Immunodeficiency Virus (HIV) DNA Load and Level of Immunosuppression in Treatment‐Naive HIV‐1–Infected Patients

    Article • The Journal of Infectious Diseases, June 2003, Oxford University Press (OUP)

    Dr Maria Rosaria Capobianchi

  220. Dynamics of viral load rebound in plasma and semen after stopping effective antiretroviral therapy

    Article • AIDS, May 2003, Wolters Kluwer Health

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  221. HCV and interferon: viral strategies for evading innate defence mechanisms in the virus-host battle

    Article • Cell Death and Differentiation, January 2003, Nature

    Dr Maria Rosaria Capobianchi

  222. Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients

    Article • AIDS, September 2002, Wolters Kluwer Health

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  223. Simple and Reliable Method for Detection and Genotyping of Hepatitis C Virus RNA in Dried Blood Spots Stored at Room Temperature

    Article • Journal of Clinical Microbiology, September 2002, ASM Journals

    Dr Maria Rosaria Capobianchi

  224. Monophyletic HIV Type 1 CRF02-AG in a Nosocomial Outbreak in Benghazi, Libya

    Article • AIDS Research and Human Retroviruses, July 2002, Mary Ann Liebert Inc

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  225. IFN system activation in liver from naive HCV chronic patients

    Article • Journal of Hepatology, April 2002, Elsevier

    Dr Maria Rosaria Capobianchi

  226. Further evidence against the implication of active cytomegalovirus infection in vascular atherosclerotic diseases

    Article • Atherosclerosis, August 2001, Elsevier

    Dr Maria Rosaria Capobianchi

  227. A new RT-PCR method for the identification of reoviruses in seawater samples

    Article • Water Research, February 2001, Elsevier

    Dr Maria Rosaria Capobianchi

  228. Decreased function of Fas in patients displaying delayed progression of HIV-induced immune deficiency

    Article • The Hematology Journal, January 2001, Nature

    Dr Maria Rosaria Capobianchi

  229. Changes in host cell molecules acquired by circulating HIV-1 in patients treated with highly active antiretroviral therapy and interleukin-2

    Article • AIDS, January 2001, Wolters Kluwer Health

    Dr Maria Rosaria Capobianchi

  230. Activation of signal transduction and apoptosis in healthy lymphomonocytes exposed to bystander HIV-1-infected cells

    Article • Clinical & Experimental Immunology, December 2000, Wiley

    Dr Maria Rosaria Capobianchi

  231. The number of HIV DNA-infected mononuclear cells is reduced under HAART plus recombinant IL-2

    Article • Antiviral Research, February 2000, Elsevier

    Dr Maria Rosaria Capobianchi

  232. RANTES Stimulates Cell-Mediated Transmission of HIV-1 Infection

    Article • Journal of Interferon & Cytokine Research, April 1999, Mary Ann Liebert Inc

    Dr Maria Rosaria Capobianchi

  233. RANTES upregulation by HIV-1-infected cells: lack of correlation with viral replication and induction of interferon

    Article • AIDS, February 1999, Wolters Kluwer Health

    Dr Maria Rosaria Capobianchi

  234. Effects of IFNα on late stages of HIV-1 replication cycle

    Article • Biochimie, August 1998, Elsevier

    Dr Maria Rosaria Capobianchi

  235. Immunomodulatory responses to δ-opioid receptor ligands in human lymphocytes

    Article • European Journal of Pharmacology, August 1997, Elsevier

    Dr Maria Rosaria Capobianchi

  236. HIV infection of endothelial cells

    Article • Perspectives in Drug Discovery and Design, December 1996, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  237. Interferon Induction by HIV-1-Infected Cells: A Possible Role of Sulfatides or Related Glycolipids

    Article • Virology, July 1996, Elsevier

    Dr Maria Rosaria Capobianchi

  238. Host cell antigenic profile acquired by HIV-1 is a marker of its cellular origin

    Article • Archives of Virology, October 1995, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  239. Antibody to ICAM-1 mediates enhancement of HIV-1 infection of human endothelial cells

    Article • Archives of Virology, May 1995, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  240. Interferon Induction by HIV Glycoprotein 120: Role of the V3 Loop

    Article • Virology, November 1994, Elsevier

    Dr Maria Rosaria Capobianchi

  241. A Simple and Reliable Method to Detect Cell Membrane Proteins on Infectious Human Immunodeficiency Virus Type 1 Particles

    Article • The Journal of Infectious Diseases, April 1994, Oxford University Press (OUP)

    Dr Maria Rosaria Capobianchi

  242. CD 4-positive lymphoid cells rescue HIV-1 replication from abortively infected human primary endothelial cells

    Article • Archives of Virology, September 1993, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  243. Interferon-alpha (IFN-alpha) production by human intestinal mononuclear cells. Response to virus in control subjects and in Crohn's disease.

    Article • Gut, July 1992, BMJ

    Dr Maria Rosaria Capobianchi

  244. Evidence against an autoimmune aetiology for inflammatory bowel diseases.

    Article • Gut, July 1992, BMJ

    Dr Maria Rosaria Capobianchi

  245. In vitro selection of human immunodeficiency virus type 1 resistant to 3′-azido-3′-deoxythymidine

    Article • Antiviral Research, May 1992, Elsevier

    Dr Maria Rosaria Capobianchi

  246. The biological basis for clinical use of interferon

    Article • Journal of Hepatology, January 1990, Elsevier

    Dr Maria Rosaria Capobianchi

  247. Susceptibility of human immunodeficiency virus to antiviral agents measured by infectious virus yield reduction

    Article • Antiviral Research, June 1989, Elsevier

    Dr Maria Rosaria Capobianchi

  248. Differences in the mechanism of induction of interferon-alpha by Herpes simplex virus and Herpes simplex virus-infected cells

    Article • Archives of Virology, September 1988, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  249. Replication of human immunodeficiency virus: yield of infectious virus under single growth cycle conditions

    Article • Archives of Virology, March 1988, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  250. Acid-labile human interferon alpha production by peripheral blood mononuclear cells stimulated by HIV-infected cells

    Article • Archives of Virology, March 1988, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  251. The Role of Interferon in Picornavirus Infections

    Article • January 1988, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  252. Membrane interactions involved in the induction of interferon-alpha by Mycoplasma pneumoniae

    Article • Antiviral Research, October 1987, Elsevier

    Dr Maria Rosaria Capobianchi

  253. [9] Induction of human immune interferon with ionophores

    Article • January 1986, Elsevier

    Dr Maria Rosaria Capobianchi

  254. Differences in the expression and release of DR, BR, and DQ molecules in human cells treated with recombinant interferon gamma: Comparison to other interferons

    Article • Human Immunology, May 1985, Elsevier

    Dr Maria Rosaria Capobianchi

  255. Induction of Alpha Interferon by Membrane Interaction between Viral Surface and Peripheral Blood Mononuclear Cells

    Article • Experimental Biology and Medicine, April 1985, SAGE Publications

    Dr Maria Rosaria Capobianchi

  256. Impaired Gamma Interferon Production by Cells from Patients with Lymphoproliferative Disorders of Mature T and NK Cells

    Article • Scandinavian Journal of Immunology, April 1985, Wiley

    Dr Maria Rosaria Capobianchi

  257. Membrane Events Leading to Interferon-  Induction by Antigens

    Article • Experimental Biology and Medicine, January 1985, SAGE Publications

    Dr Maria Rosaria Capobianchi

  258. Interferon production in primary immunodeficiencies

    Article • Journal of Clinical Immunology, September 1984, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi

  259. Defective interferon-γ production in ataxia-telangiectasia

    Article • Clinical Immunology and Immunopathology, September 1984, Elsevier

    Dr Maria Rosaria Capobianchi

  260. Human β-type interferon enhances the expression and shedding of Ia-like antigens. Comparison to HLA-A,B,C and β2-microglobulin

    Article • Antiviral Research, February 1982, Elsevier

    Dr Maria Rosaria Capobianchi

  261. Mosaicism for sulfoiduronate sulfatase deficiency in carriers of Hunter's syndrome

    Article • Cellular and Molecular Life Sciences, April 1976, Springer Science + Business Media

    Dr Maria Rosaria Capobianchi